MoneyWorks4Me

Glaxosmithkline Pharmaceuticals informs about disclosure

11 Feb 2025 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the Company has received an Order dated 4th February 2025 for the period July 2017 to March 2018 from Additional Commissioner Adjudication, Delhi-North, raising a demand of Rs 2,19,72,072 in Delhi State. The relevant details to be is disclosed is as enclosed.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.05
Dr. Reddys Labs. 1145.25
Cipla 1359.25
Lupin 2050.95
Zydus Lifesciences 1108.25
View more..